Factores predictores de la aparición de tumor residual en pacientes reintervenidas tras cirugía conservadora por cáncer de mama

Tejera Hernández, Ana Alicia; Vega Benítez, Víctor; Gutiérrez Giner, María Isabel; Trujillo Flores, Carlos David; Pérez Correa, Pedro; Hernández Hernández, Juan Ramón.
Rev. senol. patol. mamar. (Ed. impr.) ; 28(3): 120-126, sept. 2015. tab
Artículo en Español | IBECS (España) | ID: ibc-141682

Documentos relacionados

  1. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors.
  2. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
  3. Intraoperative inking is superior to suture marking for specimen orientation in breast cancer.
  4. Advances in the diagnosis and prognosis of minimal residual lesions of breast cancer.
  5. Occurrence of residual disease in specimens of re-excision surgery in patients with positive margins of primary quadrantectomy.
  6. Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.
  7. A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow.
  8. Metabolic memory underlying minimal residual disease in breast cancer.
  9. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?
  10. Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.